Cargando…
Height and body mass index in molecularly confirmed Silver–Russell syndrome and the long‐term effects of growth hormone treatment
OBJECTIVE: Silver–Russell syndrome (SRS) causes short stature. Growth hormone (GH) treatment aims to increase adult height. However, data are limited on the long‐term outcomes of GH in patients with molecularly confirmed SRS. This study evaluated height, body mass index (BMI) and GH treatment in mol...
Autores principales: | Lokulo‐Sodipe, Oluwakemi, Giabicani, Eloïse, Canton, Ana P. M., Ferrand, Nawfel, Child, Jenny, Wakeling, Emma L., Binder, Gerhard, Netchine, Irène, Mackay, Deborah J. G., Inskip, Hazel M., Byrne, Christopher D., Temple, I. Karen, Davies, Justin H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545243/ https://www.ncbi.nlm.nih.gov/pubmed/35261046 http://dx.doi.org/10.1111/cen.14715 |
Ejemplares similares
-
Phenotype of genetically confirmed Silver-Russell syndrome beyond childhood
por: Lokulo-Sodipe, Oluwakemi, et al.
Publicado: (2020) -
Discrepant molecular and clinical diagnoses in Beckwith-Wiedemann and Silver-Russell syndromes
por: Mackay, Deborah J.G., et al.
Publicado: (2019) -
Epigenotype–phenotype correlations in Silver–Russell syndrome
por: Wakeling, E L, et al.
Publicado: (2010) -
Executive functioning in adolescents and adults with Silver-Russell syndrome
por: Burgevin, Mélissa, et al.
Publicado: (2023) -
Silver-Russell syndrome: genetic basis and molecular genetic testing
por: Eggermann, Thomas, et al.
Publicado: (2010)